nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—CYP2D6—Niacin—atherosclerosis	0.153	0.3	CbGbCtD
Methylphenidate—CYP2D6—Simvastatin—atherosclerosis	0.121	0.237	CbGbCtD
Methylphenidate—CYP2D6—Pravastatin—atherosclerosis	0.118	0.232	CbGbCtD
Methylphenidate—CYP2D6—Lovastatin—atherosclerosis	0.118	0.232	CbGbCtD
Methylphenidate—Anaemia—Ezetimibe—atherosclerosis	0.000923	0.00189	CcSEcCtD
Methylphenidate—Malaise—Lovastatin—atherosclerosis	0.000918	0.00188	CcSEcCtD
Methylphenidate—Cardiac disorder—Pravastatin—atherosclerosis	0.000918	0.00187	CcSEcCtD
Methylphenidate—Flushing—Pravastatin—atherosclerosis	0.000918	0.00187	CcSEcCtD
Methylphenidate—Muscle spasms—Simvastatin—atherosclerosis	0.000916	0.00187	CcSEcCtD
Methylphenidate—Vertigo—Lovastatin—atherosclerosis	0.000915	0.00187	CcSEcCtD
Methylphenidate—Angioedema—Ezetimibe—atherosclerosis	0.000912	0.00186	CcSEcCtD
Methylphenidate—Angiopathy—Niacin—atherosclerosis	0.000911	0.00186	CcSEcCtD
Methylphenidate—Leukopenia—Lovastatin—atherosclerosis	0.000911	0.00186	CcSEcCtD
Methylphenidate—Chills—Niacin—atherosclerosis	0.000901	0.00184	CcSEcCtD
Methylphenidate—Malaise—Ezetimibe—atherosclerosis	0.0009	0.00184	CcSEcCtD
Methylphenidate—Vision blurred—Simvastatin—atherosclerosis	0.000897	0.00183	CcSEcCtD
Methylphenidate—Arrhythmia—Niacin—atherosclerosis	0.000897	0.00183	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000893	0.00182	CcSEcCtD
Methylphenidate—Tremor—Simvastatin—atherosclerosis	0.000892	0.00182	CcSEcCtD
Methylphenidate—Alopecia—Niacin—atherosclerosis	0.000888	0.00181	CcSEcCtD
Methylphenidate—Chills—Pravastatin—atherosclerosis	0.000887	0.00181	CcSEcCtD
Methylphenidate—Insomnia—Rosuvastatin—atherosclerosis	0.000887	0.00181	CcSEcCtD
Methylphenidate—Ill-defined disorder—Simvastatin—atherosclerosis	0.000884	0.0018	CcSEcCtD
Methylphenidate—Arrhythmia—Pravastatin—atherosclerosis	0.000883	0.0018	CcSEcCtD
Methylphenidate—Palpitations—Ezetimibe—atherosclerosis	0.000882	0.0018	CcSEcCtD
Methylphenidate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00088	0.0018	CcSEcCtD
Methylphenidate—Anaemia—Simvastatin—atherosclerosis	0.00088	0.0018	CcSEcCtD
Methylphenidate—Erythema—Niacin—atherosclerosis	0.000874	0.00179	CcSEcCtD
Methylphenidate—Malnutrition—Niacin—atherosclerosis	0.000874	0.00179	CcSEcCtD
Methylphenidate—Alopecia—Pravastatin—atherosclerosis	0.000874	0.00179	CcSEcCtD
Methylphenidate—Cough—Ezetimibe—atherosclerosis	0.000871	0.00178	CcSEcCtD
Methylphenidate—Angioedema—Simvastatin—atherosclerosis	0.00087	0.00178	CcSEcCtD
Methylphenidate—Myalgia—Lovastatin—atherosclerosis	0.000867	0.00177	CcSEcCtD
Methylphenidate—Chest pain—Lovastatin—atherosclerosis	0.000867	0.00177	CcSEcCtD
Methylphenidate—Arthralgia—Lovastatin—atherosclerosis	0.000867	0.00177	CcSEcCtD
Methylphenidate—Anxiety—Lovastatin—atherosclerosis	0.000864	0.00176	CcSEcCtD
Methylphenidate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000863	0.00176	CcSEcCtD
Methylphenidate—Hypertension—Ezetimibe—atherosclerosis	0.000862	0.00176	CcSEcCtD
Methylphenidate—Malaise—Simvastatin—atherosclerosis	0.000859	0.00175	CcSEcCtD
Methylphenidate—Tension—Niacin—atherosclerosis	0.000858	0.00175	CcSEcCtD
Methylphenidate—Discomfort—Lovastatin—atherosclerosis	0.000856	0.00175	CcSEcCtD
Methylphenidate—Vertigo—Simvastatin—atherosclerosis	0.000856	0.00175	CcSEcCtD
Methylphenidate—Leukopenia—Simvastatin—atherosclerosis	0.000852	0.00174	CcSEcCtD
Methylphenidate—Arthralgia—Ezetimibe—atherosclerosis	0.00085	0.00174	CcSEcCtD
Methylphenidate—Chest pain—Ezetimibe—atherosclerosis	0.00085	0.00174	CcSEcCtD
Methylphenidate—Myalgia—Ezetimibe—atherosclerosis	0.00085	0.00174	CcSEcCtD
Methylphenidate—Nervousness—Niacin—atherosclerosis	0.000849	0.00173	CcSEcCtD
Methylphenidate—Dry mouth—Lovastatin—atherosclerosis	0.000848	0.00173	CcSEcCtD
Methylphenidate—Tension—Pravastatin—atherosclerosis	0.000845	0.00173	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000844	0.00172	CcSEcCtD
Methylphenidate—Muscle spasms—Niacin—atherosclerosis	0.000841	0.00172	CcSEcCtD
Methylphenidate—Discomfort—Ezetimibe—atherosclerosis	0.00084	0.00172	CcSEcCtD
Methylphenidate—Pain—Rosuvastatin—atherosclerosis	0.000838	0.00171	CcSEcCtD
Methylphenidate—Constipation—Rosuvastatin—atherosclerosis	0.000838	0.00171	CcSEcCtD
Methylphenidate—Confusional state—Lovastatin—atherosclerosis	0.000838	0.00171	CcSEcCtD
Methylphenidate—Nervousness—Pravastatin—atherosclerosis	0.000836	0.00171	CcSEcCtD
Methylphenidate—Dry mouth—Ezetimibe—atherosclerosis	0.000831	0.0017	CcSEcCtD
Methylphenidate—Anaphylactic shock—Lovastatin—atherosclerosis	0.000831	0.0017	CcSEcCtD
Methylphenidate—Muscle spasms—Pravastatin—atherosclerosis	0.000828	0.00169	CcSEcCtD
Methylphenidate—Infection—Lovastatin—atherosclerosis	0.000825	0.00169	CcSEcCtD
Methylphenidate—Vision blurred—Niacin—atherosclerosis	0.000824	0.00168	CcSEcCtD
Methylphenidate—Confusional state—Ezetimibe—atherosclerosis	0.000822	0.00168	CcSEcCtD
Methylphenidate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000815	0.00166	CcSEcCtD
Methylphenidate—Thrombocytopenia—Lovastatin—atherosclerosis	0.000814	0.00166	CcSEcCtD
Methylphenidate—Vision blurred—Pravastatin—atherosclerosis	0.000811	0.00166	CcSEcCtD
Methylphenidate—Arthralgia—Simvastatin—atherosclerosis	0.000811	0.00166	CcSEcCtD
Methylphenidate—Chest pain—Simvastatin—atherosclerosis	0.000811	0.00166	CcSEcCtD
Methylphenidate—Myalgia—Simvastatin—atherosclerosis	0.000811	0.00166	CcSEcCtD
Methylphenidate—Infection—Ezetimibe—atherosclerosis	0.00081	0.00165	CcSEcCtD
Methylphenidate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000808	0.00165	CcSEcCtD
Methylphenidate—Anxiety—Simvastatin—atherosclerosis	0.000808	0.00165	CcSEcCtD
Methylphenidate—Tremor—Pravastatin—atherosclerosis	0.000807	0.00165	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000802	0.00164	CcSEcCtD
Methylphenidate—Discomfort—Simvastatin—atherosclerosis	0.000801	0.00164	CcSEcCtD
Methylphenidate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000799	0.00163	CcSEcCtD
Methylphenidate—Angioedema—Niacin—atherosclerosis	0.000799	0.00163	CcSEcCtD
Methylphenidate—Ill-defined disorder—Pravastatin—atherosclerosis	0.000799	0.00163	CcSEcCtD
Methylphenidate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000798	0.00163	CcSEcCtD
Methylphenidate—Anaemia—Pravastatin—atherosclerosis	0.000796	0.00163	CcSEcCtD
Methylphenidate—Anorexia—Lovastatin—atherosclerosis	0.000792	0.00162	CcSEcCtD
Methylphenidate—Skin disorder—Ezetimibe—atherosclerosis	0.000792	0.00162	CcSEcCtD
Methylphenidate—Angioedema—Pravastatin—atherosclerosis	0.000787	0.00161	CcSEcCtD
Methylphenidate—Vertigo—Niacin—atherosclerosis	0.000786	0.0016	CcSEcCtD
Methylphenidate—Syncope—Niacin—atherosclerosis	0.000784	0.0016	CcSEcCtD
Methylphenidate—Confusional state—Simvastatin—atherosclerosis	0.000784	0.0016	CcSEcCtD
Methylphenidate—Leukopenia—Niacin—atherosclerosis	0.000783	0.0016	CcSEcCtD
Methylphenidate—Urticaria—Rosuvastatin—atherosclerosis	0.000779	0.00159	CcSEcCtD
Methylphenidate—Anaphylactic shock—Simvastatin—atherosclerosis	0.000777	0.00159	CcSEcCtD
Methylphenidate—Oedema—Simvastatin—atherosclerosis	0.000777	0.00159	CcSEcCtD
Methylphenidate—Malaise—Pravastatin—atherosclerosis	0.000776	0.00159	CcSEcCtD
Methylphenidate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000775	0.00158	CcSEcCtD
Methylphenidate—Vertigo—Pravastatin—atherosclerosis	0.000773	0.00158	CcSEcCtD
Methylphenidate—Palpitations—Niacin—atherosclerosis	0.000773	0.00158	CcSEcCtD
Methylphenidate—Infection—Simvastatin—atherosclerosis	0.000772	0.00158	CcSEcCtD
Methylphenidate—Leukopenia—Pravastatin—atherosclerosis	0.000771	0.00157	CcSEcCtD
Methylphenidate—Loss of consciousness—Niacin—atherosclerosis	0.000769	0.00157	CcSEcCtD
Methylphenidate—Cough—Niacin—atherosclerosis	0.000763	0.00156	CcSEcCtD
Methylphenidate—Thrombocytopenia—Simvastatin—atherosclerosis	0.000761	0.00155	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000757	0.00155	CcSEcCtD
Methylphenidate—Insomnia—Lovastatin—atherosclerosis	0.000752	0.00154	CcSEcCtD
Methylphenidate—Cough—Pravastatin—atherosclerosis	0.000751	0.00153	CcSEcCtD
Methylphenidate—Paraesthesia—Lovastatin—atherosclerosis	0.000746	0.00152	CcSEcCtD
Methylphenidate—Arthralgia—Niacin—atherosclerosis	0.000744	0.00152	CcSEcCtD
Methylphenidate—Myalgia—Niacin—atherosclerosis	0.000744	0.00152	CcSEcCtD
Methylphenidate—Hypertension—Pravastatin—atherosclerosis	0.000743	0.00152	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000742	0.00152	CcSEcCtD
Methylphenidate—Anorexia—Simvastatin—atherosclerosis	0.000741	0.00151	CcSEcCtD
Methylphenidate—Dyspnoea—Lovastatin—atherosclerosis	0.000741	0.00151	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000739	0.00151	CcSEcCtD
Methylphenidate—Insomnia—Ezetimibe—atherosclerosis	0.000737	0.00151	CcSEcCtD
Methylphenidate—Myalgia—Pravastatin—atherosclerosis	0.000733	0.0015	CcSEcCtD
Methylphenidate—Arthralgia—Pravastatin—atherosclerosis	0.000733	0.0015	CcSEcCtD
Methylphenidate—Chest pain—Pravastatin—atherosclerosis	0.000733	0.0015	CcSEcCtD
Methylphenidate—Paraesthesia—Ezetimibe—atherosclerosis	0.000732	0.00149	CcSEcCtD
Methylphenidate—Dyspepsia—Lovastatin—atherosclerosis	0.000731	0.00149	CcSEcCtD
Methylphenidate—Anxiety—Pravastatin—atherosclerosis	0.00073	0.00149	CcSEcCtD
Methylphenidate—Dry mouth—Niacin—atherosclerosis	0.000728	0.00149	CcSEcCtD
Methylphenidate—Dyspnoea—Ezetimibe—atherosclerosis	0.000727	0.00148	CcSEcCtD
Methylphenidate—Discomfort—Pravastatin—atherosclerosis	0.000724	0.00148	CcSEcCtD
Methylphenidate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000722	0.00148	CcSEcCtD
Methylphenidate—Decreased appetite—Lovastatin—atherosclerosis	0.000722	0.00148	CcSEcCtD
Methylphenidate—Dyspepsia—Ezetimibe—atherosclerosis	0.000717	0.00147	CcSEcCtD
Methylphenidate—Fatigue—Lovastatin—atherosclerosis	0.000716	0.00146	CcSEcCtD
Methylphenidate—Anaphylactic shock—Niacin—atherosclerosis	0.000714	0.00146	CcSEcCtD
Methylphenidate—Oedema—Niacin—atherosclerosis	0.000714	0.00146	CcSEcCtD
Methylphenidate—Constipation—Lovastatin—atherosclerosis	0.000711	0.00145	CcSEcCtD
Methylphenidate—Pain—Lovastatin—atherosclerosis	0.000711	0.00145	CcSEcCtD
Methylphenidate—Confusional state—Pravastatin—atherosclerosis	0.000708	0.00145	CcSEcCtD
Methylphenidate—Decreased appetite—Ezetimibe—atherosclerosis	0.000708	0.00145	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000708	0.00145	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000704	0.00144	CcSEcCtD
Methylphenidate—Asthenia—Rosuvastatin—atherosclerosis	0.000703	0.00144	CcSEcCtD
Methylphenidate—Insomnia—Simvastatin—atherosclerosis	0.000703	0.00144	CcSEcCtD
Methylphenidate—Anaphylactic shock—Pravastatin—atherosclerosis	0.000703	0.00144	CcSEcCtD
Methylphenidate—Oedema—Pravastatin—atherosclerosis	0.000703	0.00144	CcSEcCtD
Methylphenidate—Fatigue—Ezetimibe—atherosclerosis	0.000703	0.00144	CcSEcCtD
Methylphenidate—Shock—Niacin—atherosclerosis	0.000702	0.00143	CcSEcCtD
Methylphenidate—Infection—Pravastatin—atherosclerosis	0.000698	0.00143	CcSEcCtD
Methylphenidate—Paraesthesia—Simvastatin—atherosclerosis	0.000698	0.00143	CcSEcCtD
Methylphenidate—Constipation—Ezetimibe—atherosclerosis	0.000697	0.00142	CcSEcCtD
Methylphenidate—Pain—Ezetimibe—atherosclerosis	0.000697	0.00142	CcSEcCtD
Methylphenidate—Tachycardia—Niacin—atherosclerosis	0.000696	0.00142	CcSEcCtD
Methylphenidate—Pruritus—Rosuvastatin—atherosclerosis	0.000694	0.00142	CcSEcCtD
Methylphenidate—Skin disorder—Niacin—atherosclerosis	0.000693	0.00142	CcSEcCtD
Methylphenidate—Dyspnoea—Simvastatin—atherosclerosis	0.000693	0.00142	CcSEcCtD
Methylphenidate—Hyperhidrosis—Niacin—atherosclerosis	0.00069	0.00141	CcSEcCtD
Methylphenidate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000688	0.00141	CcSEcCtD
Methylphenidate—Feeling abnormal—Lovastatin—atherosclerosis	0.000685	0.0014	CcSEcCtD
Methylphenidate—Dyspepsia—Simvastatin—atherosclerosis	0.000684	0.0014	CcSEcCtD
Methylphenidate—Anorexia—Niacin—atherosclerosis	0.00068	0.00139	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000679	0.00139	CcSEcCtD
Methylphenidate—Hyperhidrosis—Pravastatin—atherosclerosis	0.000679	0.00139	CcSEcCtD
Methylphenidate—Decreased appetite—Simvastatin—atherosclerosis	0.000676	0.00138	CcSEcCtD
Methylphenidate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000672	0.00137	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000671	0.00137	CcSEcCtD
Methylphenidate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000671	0.00137	CcSEcCtD
Methylphenidate—Fatigue—Simvastatin—atherosclerosis	0.00067	0.00137	CcSEcCtD
Methylphenidate—Anorexia—Pravastatin—atherosclerosis	0.00067	0.00137	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000666	0.00136	CcSEcCtD
Methylphenidate—Pain—Simvastatin—atherosclerosis	0.000665	0.00136	CcSEcCtD
Methylphenidate—Constipation—Simvastatin—atherosclerosis	0.000665	0.00136	CcSEcCtD
Methylphenidate—Urticaria—Lovastatin—atherosclerosis	0.00066	0.00135	CcSEcCtD
Methylphenidate—Abdominal pain—Lovastatin—atherosclerosis	0.000657	0.00134	CcSEcCtD
Methylphenidate—Body temperature increased—Lovastatin—atherosclerosis	0.000657	0.00134	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00065	0.00133	CcSEcCtD
Methylphenidate—Dizziness—Rosuvastatin—atherosclerosis	0.000648	0.00132	CcSEcCtD
Methylphenidate—Urticaria—Ezetimibe—atherosclerosis	0.000647	0.00132	CcSEcCtD
Methylphenidate—Insomnia—Niacin—atherosclerosis	0.000645	0.00132	CcSEcCtD
Methylphenidate—Abdominal pain—Ezetimibe—atherosclerosis	0.000644	0.00132	CcSEcCtD
Methylphenidate—Body temperature increased—Ezetimibe—atherosclerosis	0.000644	0.00132	CcSEcCtD
Methylphenidate—Paraesthesia—Niacin—atherosclerosis	0.000641	0.00131	CcSEcCtD
Methylphenidate—Feeling abnormal—Simvastatin—atherosclerosis	0.00064	0.00131	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00064	0.00131	CcSEcCtD
Methylphenidate—Dyspnoea—Niacin—atherosclerosis	0.000636	0.0013	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000636	0.0013	CcSEcCtD
Methylphenidate—Insomnia—Pravastatin—atherosclerosis	0.000636	0.0013	CcSEcCtD
Methylphenidate—Somnolence—Niacin—atherosclerosis	0.000634	0.0013	CcSEcCtD
Methylphenidate—Paraesthesia—Pravastatin—atherosclerosis	0.000631	0.00129	CcSEcCtD
Methylphenidate—Dyspepsia—Niacin—atherosclerosis	0.000628	0.00128	CcSEcCtD
Methylphenidate—Dyspnoea—Pravastatin—atherosclerosis	0.000626	0.00128	CcSEcCtD
Methylphenidate—Decreased appetite—Niacin—atherosclerosis	0.00062	0.00127	CcSEcCtD
Methylphenidate—Dyspepsia—Pravastatin—atherosclerosis	0.000618	0.00126	CcSEcCtD
Methylphenidate—Rash—Rosuvastatin—atherosclerosis	0.000618	0.00126	CcSEcCtD
Methylphenidate—Dermatitis—Rosuvastatin—atherosclerosis	0.000618	0.00126	CcSEcCtD
Methylphenidate—Urticaria—Simvastatin—atherosclerosis	0.000617	0.00126	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000616	0.00126	CcSEcCtD
Methylphenidate—Abdominal pain—Simvastatin—atherosclerosis	0.000614	0.00125	CcSEcCtD
Methylphenidate—Body temperature increased—Simvastatin—atherosclerosis	0.000614	0.00125	CcSEcCtD
Methylphenidate—Headache—Rosuvastatin—atherosclerosis	0.000614	0.00125	CcSEcCtD
Methylphenidate—Hypersensitivity—Lovastatin—atherosclerosis	0.000612	0.00125	CcSEcCtD
Methylphenidate—Decreased appetite—Pravastatin—atherosclerosis	0.000611	0.00125	CcSEcCtD
Methylphenidate—Pain—Niacin—atherosclerosis	0.00061	0.00125	CcSEcCtD
Methylphenidate—Fatigue—Pravastatin—atherosclerosis	0.000606	0.00124	CcSEcCtD
Methylphenidate—Pain—Pravastatin—atherosclerosis	0.000601	0.00123	CcSEcCtD
Methylphenidate—Constipation—Pravastatin—atherosclerosis	0.000601	0.00123	CcSEcCtD
Methylphenidate—Hypersensitivity—Ezetimibe—atherosclerosis	0.0006	0.00123	CcSEcCtD
Methylphenidate—Asthenia—Lovastatin—atherosclerosis	0.000596	0.00122	CcSEcCtD
Methylphenidate—Pruritus—Lovastatin—atherosclerosis	0.000588	0.0012	CcSEcCtD
Methylphenidate—Asthenia—Ezetimibe—atherosclerosis	0.000585	0.00119	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Niacin—atherosclerosis	0.000584	0.00119	CcSEcCtD
Methylphenidate—Nausea—Rosuvastatin—atherosclerosis	0.000582	0.00119	CcSEcCtD
Methylphenidate—Feeling abnormal—Pravastatin—atherosclerosis	0.000579	0.00118	CcSEcCtD
Methylphenidate—Pruritus—Ezetimibe—atherosclerosis	0.000577	0.00118	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000575	0.00117	CcSEcCtD
Methylphenidate—Hypersensitivity—Simvastatin—atherosclerosis	0.000573	0.00117	CcSEcCtD
Methylphenidate—Diarrhoea—Lovastatin—atherosclerosis	0.000569	0.00116	CcSEcCtD
Methylphenidate—Urticaria—Niacin—atherosclerosis	0.000567	0.00116	CcSEcCtD
Methylphenidate—Abdominal pain—Niacin—atherosclerosis	0.000564	0.00115	CcSEcCtD
Methylphenidate—Body temperature increased—Niacin—atherosclerosis	0.000564	0.00115	CcSEcCtD
Methylphenidate—Urticaria—Pravastatin—atherosclerosis	0.000558	0.00114	CcSEcCtD
Methylphenidate—Asthenia—Simvastatin—atherosclerosis	0.000558	0.00114	CcSEcCtD
Methylphenidate—Diarrhoea—Ezetimibe—atherosclerosis	0.000558	0.00114	CcSEcCtD
Methylphenidate—Abdominal pain—Pravastatin—atherosclerosis	0.000555	0.00113	CcSEcCtD
Methylphenidate—Body temperature increased—Pravastatin—atherosclerosis	0.000555	0.00113	CcSEcCtD
Methylphenidate—Pruritus—Simvastatin—atherosclerosis	0.00055	0.00112	CcSEcCtD
Methylphenidate—Dizziness—Lovastatin—atherosclerosis	0.000549	0.00112	CcSEcCtD
Methylphenidate—Dizziness—Ezetimibe—atherosclerosis	0.000539	0.0011	CcSEcCtD
Methylphenidate—Diarrhoea—Simvastatin—atherosclerosis	0.000532	0.00109	CcSEcCtD
Methylphenidate—Vomiting—Lovastatin—atherosclerosis	0.000528	0.00108	CcSEcCtD
Methylphenidate—Hypersensitivity—Niacin—atherosclerosis	0.000526	0.00107	CcSEcCtD
Methylphenidate—Rash—Lovastatin—atherosclerosis	0.000524	0.00107	CcSEcCtD
Methylphenidate—Dermatitis—Lovastatin—atherosclerosis	0.000523	0.00107	CcSEcCtD
Methylphenidate—Headache—Lovastatin—atherosclerosis	0.000521	0.00106	CcSEcCtD
Methylphenidate—Vomiting—Ezetimibe—atherosclerosis	0.000518	0.00106	CcSEcCtD
Methylphenidate—Hypersensitivity—Pravastatin—atherosclerosis	0.000518	0.00106	CcSEcCtD
Methylphenidate—Dizziness—Simvastatin—atherosclerosis	0.000514	0.00105	CcSEcCtD
Methylphenidate—Rash—Ezetimibe—atherosclerosis	0.000514	0.00105	CcSEcCtD
Methylphenidate—Dermatitis—Ezetimibe—atherosclerosis	0.000513	0.00105	CcSEcCtD
Methylphenidate—Asthenia—Niacin—atherosclerosis	0.000512	0.00105	CcSEcCtD
Methylphenidate—Headache—Ezetimibe—atherosclerosis	0.000511	0.00104	CcSEcCtD
Methylphenidate—Pruritus—Niacin—atherosclerosis	0.000505	0.00103	CcSEcCtD
Methylphenidate—Asthenia—Pravastatin—atherosclerosis	0.000504	0.00103	CcSEcCtD
Methylphenidate—Pruritus—Pravastatin—atherosclerosis	0.000497	0.00102	CcSEcCtD
Methylphenidate—Vomiting—Simvastatin—atherosclerosis	0.000494	0.00101	CcSEcCtD
Methylphenidate—Nausea—Lovastatin—atherosclerosis	0.000494	0.00101	CcSEcCtD
Methylphenidate—Rash—Simvastatin—atherosclerosis	0.00049	0.001	CcSEcCtD
Methylphenidate—Dermatitis—Simvastatin—atherosclerosis	0.00049	0.001	CcSEcCtD
Methylphenidate—Diarrhoea—Niacin—atherosclerosis	0.000488	0.000997	CcSEcCtD
Methylphenidate—Headache—Simvastatin—atherosclerosis	0.000487	0.000994	CcSEcCtD
Methylphenidate—Nausea—Ezetimibe—atherosclerosis	0.000484	0.000989	CcSEcCtD
Methylphenidate—Diarrhoea—Pravastatin—atherosclerosis	0.000481	0.000982	CcSEcCtD
Methylphenidate—Dizziness—Niacin—atherosclerosis	0.000472	0.000964	CcSEcCtD
Methylphenidate—Dizziness—Pravastatin—atherosclerosis	0.000465	0.000949	CcSEcCtD
Methylphenidate—Nausea—Simvastatin—atherosclerosis	0.000462	0.000943	CcSEcCtD
Methylphenidate—Vomiting—Niacin—atherosclerosis	0.000454	0.000927	CcSEcCtD
Methylphenidate—Rash—Niacin—atherosclerosis	0.00045	0.000919	CcSEcCtD
Methylphenidate—Dermatitis—Niacin—atherosclerosis	0.00045	0.000918	CcSEcCtD
Methylphenidate—Headache—Niacin—atherosclerosis	0.000447	0.000913	CcSEcCtD
Methylphenidate—Vomiting—Pravastatin—atherosclerosis	0.000447	0.000913	CcSEcCtD
Methylphenidate—Rash—Pravastatin—atherosclerosis	0.000443	0.000905	CcSEcCtD
Methylphenidate—Dermatitis—Pravastatin—atherosclerosis	0.000443	0.000904	CcSEcCtD
Methylphenidate—Headache—Pravastatin—atherosclerosis	0.00044	0.000899	CcSEcCtD
Methylphenidate—Nausea—Niacin—atherosclerosis	0.000424	0.000866	CcSEcCtD
Methylphenidate—Nausea—Pravastatin—atherosclerosis	0.000417	0.000852	CcSEcCtD
